TickerFacts.

Yatsen Holding Ltd (YSG): R&D Expense

Annual figures by period end, from SEC filings.

137.30M CNY
Year ended 2025-12-31
+2.7%
3-year compound annual growth
+15.6%
5-year compound annual growth
142.09M CNY2018-12-31: 2.64M CNY2019-12-31: 23.18M CNY2020-12-31: 66.51M CNY2021-12-31: 142.09M CNY2022-12-31: 126.88M CNY2023-12-31: 111.70M CNY2024-12-31: 109.29M CNY2025-12-31: 137.30M CNY137.30M CNY
2018-12-31 R&D Expense (CNY) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31137.30M CNY+25.6%2026-04-29, From 2025-01-01
2024-12-31109.29M CNY-2.2%2026-04-29, From 2024-01-01
2023-12-31111.70M CNY-12.0%2026-04-29, From 2023-01-01
2022-12-31126.88M CNY-10.7%2025-04-22, From 2022-01-01
2021-12-31142.09M CNY+113.6%2024-04-26, From 2021-01-01
2020-12-3166.51M CNY+186.9%2023-04-26, From 2020-01-01
2019-12-3123.18M CNY+777.7%2022-04-22, From 2019-01-01
2018-12-312.64M CNYn/a2021-04-21, From 2018-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Perfumes, Cosmetics & Other Toilet Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Yatsen Holding Ltd (YSG)2025-12-31137.30M CNY+25.6%
Zhengye Biotechnology Holding Ltd (ZYBT)2025-12-3118.01M CNY+40.8%

Compare YSG, ZYBT side by side · Screen every company in Perfumes, Cosmetics & Other Toilet Preparations ↗